Literature DB >> 20586704

Native albumin for targeted drug delivery.

Elena Neumann1, Eva Frei, Dorothee Funk, Matthias D Becker, Hans-Hermann Schrenk, Ulf Müller-Ladner, Christoph Fiehn.   

Abstract

UNLABELLED: IMPORTANCE IN THE FIELD: Activated cells metabolize albumin to cover their increased need for amino acids and energy. In inflamed, diseased and malignant tissue, extravasation of macromolecules into the tissue is upregulated. Drug carriers such as albumin have been used to target specifically diseased and malignant cells, resulting in higher efficacy of treatment and reduced side effects. AREAS COVERED IN THIS REVIEW: Owing to its advantageous biochemical and pharmacological properties, albumin has been regarded as an interesting candidate as a drug carrier. Covalent coupling to albumin carries drugs specifically to tumors and sites of inflammation, leading to reduced side effects as long as the native structure of albumin is unchanged. In this review, the means of coupling drugs to native albumin as well as exemplary studies for the use of albumin as drug carrier are summarized and discussed. WHAT THE READER WILL GAIN: An overview of the state-of-the-art using albumin as drug carrier for specific accumulation in tumors and inflammatory cells using the advantageous properties of native albumin is given in this review. TAKE HOME MESSAGE: Native albumin is an effective drug carrier to sites of inflammation or malignancy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20586704     DOI: 10.1517/17425247.2010.498474

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  23 in total

1.  Monoclonal antibodies directed against human FcRn and their applications.

Authors:  Gregory J Christianson; Victor Z Sun; Shreeram Akilesh; Emanuele Pesavento; Gabriele Proetzel; Derry C Roopenian
Journal:  MAbs       Date:  2012-03-01       Impact factor: 5.857

2.  Dragon fruit-like biocage as an iron trapping nanoplatform for high efficiency targeted cancer multimodality imaging.

Authors:  Min Yang; Quli Fan; Ruiping Zhang; Kai Cheng; Junjie Yan; Donghui Pan; Xiaowei Ma; Alex Lu; Zhen Cheng
Journal:  Biomaterials       Date:  2015-08-05       Impact factor: 12.479

3.  Recent advances in nanoengineering cellulose for cargo delivery.

Authors:  Amir Sheikhi; Joel Hayashi; James Eichenbaum; Mark Gutin; Nicole Kuntjoro; Danial Khorsandi; Ali Khademhosseini
Journal:  J Control Release       Date:  2018-11-27       Impact factor: 9.776

4.  Lipophilic siRNA targets albumin in situ and promotes bioavailability, tumor penetration, and carrier-free gene silencing.

Authors:  Samantha M Sarett; Thomas A Werfel; Linus Lee; Meredith A Jackson; Kameron V Kilchrist; Dana Brantley-Sieders; Craig L Duvall
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-24       Impact factor: 11.205

Review 5.  The determination and interpretation of the therapeutic index in drug development.

Authors:  Patrick Y Muller; Mark N Milton
Journal:  Nat Rev Drug Discov       Date:  2012-08-31       Impact factor: 84.694

6.  Photochemically generated elemental selenium forms conjugates with serum proteins that are preferentially cytotoxic to leukemia and selected solid tumor cells.

Authors:  Jean-Pierre Daziano; Wolfgang H H Günther; Marianne Krieg; Ichiro Tsujino; Kiyoko Miyagi; Gregory S Anderson; Reynée W Sampson; Martin D Ostrowski; Sarah A Muir; Raymond J Bula; Fritz Sieber
Journal:  Photochem Photobiol       Date:  2012-01-31       Impact factor: 3.421

7.  Magnitude of enhanced permeability and retention effect in tumors with different phenotypes: 89Zr-albumin as a model system.

Authors:  Carola Heneweer; Jason P Holland; Vadim Divilov; Sean Carlin; Jason S Lewis
Journal:  J Nucl Med       Date:  2011-03-18       Impact factor: 10.057

8.  Visualizing HIF-1α mRNA in a Subpopulation of Bone Marrow-Derived Cells to Predict Retinal Neovascularization.

Authors:  Md Imam Uddin; Tyler C Kilburn; Craig L Duvall; John S Penn
Journal:  ACS Chem Biol       Date:  2020-10-20       Impact factor: 5.100

Review 9.  Simple bioconjugate chemistry serves great clinical advances: albumin as a versatile platform for diagnosis and precision therapy.

Authors:  Zhibo Liu; Xiaoyuan Chen
Journal:  Chem Soc Rev       Date:  2016-03-07       Impact factor: 54.564

10.  Development and Validation of a Small Single-domain Antibody That Effectively Inhibits Matrix Metalloproteinase 8.

Authors:  Delphine Demeestere; Eline Dejonckheere; Sophie Steeland; Paco Hulpiau; Jurgen Haustraete; Nick Devoogdt; Rielana Wichert; Christoph Becker-Pauly; Elien Van Wonterghem; Sylviane Dewaele; Griet Van Imschoot; Jeroen Aerts; Lutgarde Arckens; Yvan Saeys; Claude Libert; Roosmarijn E Vandenbroucke
Journal:  Mol Ther       Date:  2016-01-18       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.